Aptus Pharma Board Meeting for H1 FY26 Results

In accordance with the Company's Code of Conduct for Prohibition of Insider Trading pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and as per the company's earlier intimation dated 28/09/2026, the Trading Window for dealing in the Company's securities has been closed from October 1, 2026. The Trading Window shall remain closed until completion of 48 hours after the declaration of the said financial results.

The disclosure is signed by Tejash Maheshchandra Hathi, Managing Director (DIN: 03151221), and addressed to the Corporate Relation Departments of The BSE Limited at Phiroze Jeejeebhoy Tower, Dalal Street, Mumbai – 400001.

Company registration details: CIN: U24230GJ2010PLC061957, GSTIN: 24AAICA7890D1ZM

Registered Address: Ashutosh Buildcon, Opp. Slok – 2, Nr. Harikrupa Logistic Park, Aslali, Daskroi, Ahmedabad, Gujarat – 382427, India